NTRK1 and ovarian cancer: At the same time, ERBB3 is a tyrosine kinase receptor often activated in ovarian cancer and perturbation of ERBB3-dependent signal transduction by RNA interference resulted in decrease disease progression and prolonged survival in murine models, identifying ERBB3 as a potential therapeutic target in ovarian cancer [49].